health
Phase 2b trial tests VCN-01 with chemotherapy for metastatic pancreatic cancer
A randomized phase 2b trial compared the oncolytic adenovirus VCN-01 plus chemotherapy with chemotherapy alone as first-line treatment for metastatic pancreatic cancer. Progression-free survival was longer in the VCN-01 group, while overall-survival results differed between the trial’s analysis populations.